SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-19-005165
Filing Date
2019-04-24
Accepted
2019-04-24 21:43:42
Documents
2
Period of Report
2019-04-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4426
2 POWER OF ATTORNEY ex24toselli.txt EX-24.1 4081
  Complete submission text file 0001179110-19-005165.txt   10072
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O INVIVO THERAPEUTICS HOLDINGS CORP. 1 KENDALL SQUARE, SUITE B14402 CAMBRIDGE MA 02139
Business Address
Toselli Richard M. (Reporting) CIK: 0001710549 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37350 | Film No.: 19765131